Vitalhub (TSE:VHI) Stock Rating Upgraded by Raymond James

Vitalhub (TSE:VHI) was upgraded by investment analysts at Raymond James to a “moderate buy” rating in a research note issued on Wednesday,Zacks.com reports.

Several other research analysts have also weighed in on VHI. Scotiabank set a C$14.00 target price on shares of Vitalhub and gave the stock an “outperform” rating in a research report on Thursday, January 30th. Canaccord Genuity Group upped their price target on Vitalhub from C$12.00 to C$12.50 and gave the stock a “buy” rating in a report on Thursday, January 16th. Four analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of C$11.92.

Vitalhub Stock Performance

TSE:VHI opened at C$9.66 on Wednesday. Vitalhub has a 1 year low of C$5.80 and a 1 year high of C$12.09. The stock has a fifty day moving average price of C$10.49 and a two-hundred day moving average price of C$10.31. The stock has a market capitalization of C$522.53 million, a price-to-earnings ratio of 157.12, a PEG ratio of 1.18 and a beta of 1.26.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.